Search research articles
Contact Us
Filters
Showing results (1-10 of 97) with videos related to
Page
of 10
Sort By:
British Journal of Pharmacology
|
August 20, 2016
The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations
Stefania Petrosino, Vincenzo Di Marzo
Current Opinion in Investigational Drugs (London, England : 2000)
|
January 5, 2010
FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels
Stefania Petrosino, Vincenzo Di Marzo
International Journal of Molecular Sciences
|
December 18, 2020
Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries-A Systematic Review
Stefania Petrosino, Aniello Schiano Moriello
Current Opinion in Lipidology
|
March 14, 2007
Endocannabinoids and the regulation of their levels in health and disease
Vincenzo Di Marzo, Stefania Petrosino
Current Opinion in Chemical Biology
|
May 22, 2009
Endocannabinoid chemical biology: a tool for the development of novel therapies
Stefania Petrosino, Alessia Ligresti, Vincenzo Di Marzo
Biochimie
|
January 26, 2010
N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities
Stefania Petrosino, Teresa Iuvone, Vincenzo Di Marzo
Current Opinion in Chemical Biology
|
June 6, 2009
From endocannabinoid profiling to 'endocannabinoid therapeutics'
Alessia Ligresti, Stefania Petrosino, Vincenzo Di Marzo
Progress in Lipid Research
|
March 12, 2016
Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders
Fabio Arturo Iannotti, Vincenzo Di Marzo, Stefania Petrosino
Animals : an Open Access Journal From MDPI
|
February 15, 2022
Mutual Links between the Endocannabinoidome and the Gut Microbiome, with Special Reference to Companion Animals: A Nutritional Viewpoint
Aniello Schiano Moriello, Vincenzo Di Marzo, Stefania Petrosino
Neurochemistry International
|
August 1, 2007
Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6/2 mice, a transgenic model of Huntington's disease
Tiziana Bisogno, Alberto Martire, Stefania Petrosino, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 97) with videos related to
Sort By:
Page
of 10
British Journal of Pharmacology
|
August 20, 2016
The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations
Stefania Petrosino, Vincenzo Di Marzo
Current Opinion in Investigational Drugs (London, England : 2000)
|
January 5, 2010
FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels
Stefania Petrosino, Vincenzo Di Marzo
International Journal of Molecular Sciences
|
December 18, 2020
Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries-A Systematic Review
Stefania Petrosino, Aniello Schiano Moriello
Current Opinion in Lipidology
|
March 14, 2007
Endocannabinoids and the regulation of their levels in health and disease
Vincenzo Di Marzo, Stefania Petrosino
Current Opinion in Chemical Biology
|
May 22, 2009
Endocannabinoid chemical biology: a tool for the development of novel therapies
Stefania Petrosino, Alessia Ligresti, Vincenzo Di Marzo
Biochimie
|
January 26, 2010
N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities
Stefania Petrosino, Teresa Iuvone, Vincenzo Di Marzo
Current Opinion in Chemical Biology
|
June 6, 2009
From endocannabinoid profiling to 'endocannabinoid therapeutics'
Alessia Ligresti, Stefania Petrosino, Vincenzo Di Marzo
Progress in Lipid Research
|
March 12, 2016
Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders
Fabio Arturo Iannotti, Vincenzo Di Marzo, Stefania Petrosino
Animals : an Open Access Journal From MDPI
|
February 15, 2022
Mutual Links between the Endocannabinoidome and the Gut Microbiome, with Special Reference to Companion Animals: A Nutritional Viewpoint
Aniello Schiano Moriello, Vincenzo Di Marzo, Stefania Petrosino
Neurochemistry International
|
August 1, 2007
Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6/2 mice, a transgenic model of Huntington's disease
Tiziana Bisogno, Alberto Martire, Stefania Petrosino, et al.
Page
of 10